Moreover, treatment of liver cancer cells with 3-MA, an inhibitor of autophagy induction, caused significant alleviation of LC3-II accumulation triggered by UBE2F knockdown (Fig. 1L), indicating a causal involvement of autophagy induction. Here, UBE2F is linked to liver cancer.